KNSA · Kiniksa Pharmaceuticals, Ltd.
SELL 87%
334
Total trades
12
Insiders on record
87%
Avg confidence
SELL
Signal direction
Recent insider trades
| Date | Insider | Action | Type | Value | Confidence |
|---|---|---|---|---|---|
| Apr 6, 2026 | Ross Moat | SELL | Open-market sale | 115K | 1.00 |
| Mar 9, 2026 | Mark Ragosa | SELL | Open-market sale | 819.6K | 1.00 |
| Mar 2, 2026 | John Paolini | SELL | Open-market sale | 533.2K | 0.96 |
| Feb 12, 2026 | Barry D Quart | SELL | Open-market sale | 121.1K | 0.82 |
| Feb 10, 2026 | Barry D Quart | SELL | Open-market sale | 5K | 0.73 |
| Feb 9, 2026 | Mark Ragosa | SELL | Open-market sale | 390.5K | 1.00 |
| Feb 4, 2026 | Barry D Quart | SELL | Open-market sale | 117.1K | 0.82 |
| Feb 3, 2026 | Barry D Quart | SELL | Open-market sale | 567.1K | 0.92 |
| Feb 2, 2026 | Barry D Quart | SELL | Open-market sale | 37.4K | 0.76 |
| Jan 8, 2026 | Mark Ragosa | SELL | Open-market sale | 502.7K | 1.00 |
Kiniksa Pharmaceuticals, Ltd. has 334 total insider trades on record. Sign up to see the full history, track records, and evidence trails.
Want alerts when insiders trade KNSA?
Sign up free to get notified, see the full trade history, and track insider conviction over time.
Sign up freeInsiderTrack aggregates publicly available SEC Form 4 filings. Data is provided for informational purposes only and should not be construed as investment advice. Always do your own research before making investment decisions.